EXCLUSIVE: The latest figures are all too clear: we are in the middle of an epidemic of diabetes.

Beacon Journal sports writer George M. Thomas shares his story of renal disease and subsequent kidney transplant.

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Bayer has launched a digital patient support package in England designed to help people with type 2 diabetes look after the health of their kidneys and avoid progression to chronic kidney disease ...

Johnson & Johnson's Invokana (canagliflozin) meanwhile also has an indication for diabetic kidney disease, but has been affected by side effect concerns which – while resolved – have sent its ...

Researchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of the lesions that occur in chronic ...

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

"Heart failure and kidney failure often go hand in hand," he told Newsweek, adding that the kidneys control the way the body handles salt and water. If they are not getting rid of these substances ...